GlassScriptPhysician profile
Kelly Carmichael
NPI 1669836979
$6,225.38
in general payments reported to CMS, 2019-2025
36 companies · $2,485 in 2025
The $2,485 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $478 · 2022: $1,500 · 2023: $1,082 · 2024: $680 · 2025: $2,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,246.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $488.04 | 2022-2025 | Evenity, Repatha, Tepezza |
| Teva Pharmaceuticals USA, INC. | $381.78 | 2022-2025 | Uzedy |
| Alexion Pharmaceuticals, INC. | $379.60 | 2023-2025 | Ultomiris, Soliris |
| Alnylam Pharmaceuticals INC. | $357.52 | 2023-2025 | Amvuttra, Givlaari |
| Glaxosmithkline, LLC. | $334.82 | 2021-2025 | Benlysta |
| Novo Nordisk INC | $322.97 | 2021-2023 | Wegovy |
| Boston Scientific Corporation | $283.92 | 2022-2025 | Watchman Flx |
| Abbvie INC. | $279.88 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $243.95 | 2024-2025 | |
| Axsome Therapeutics, INC. | $240.68 | 2024-2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $189.82 | 2023-2025 | |
| Corcept Therapeutics | $179.82 | 2021-2025 | Korlym |
| Pfizer INC. | $165.35 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $160.39 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $160.24 | 2022-2023 | Farxiga |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Carmichael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.